Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis

NCT05101447 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped funding not secured

Conditions

Lupus Nephritis

Interventions

DRUG: Mycophenolate Mofetil

Sponsor

Children's Hospital Medical Center, Cincinnati